The long-term prognosis of Krabbe disease has historically been grim, with infantile-onset cases typically leading to death by age 2-4. However, emerging therapies—including improved HSCT protocols, enzyme replacements, and gene therapies—are transforming expectations, offering hope for extended survival and improved quality of life. Understanding these shifts is vital for patients,...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
